Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sonia Seng"'
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 5 (2011)
Castration resistant prostate cancer has historically been considered chemotherapy insensitive. However, the approval of estramustine phosphate, mitoxantrone, and docetaxel, over the past few decades, has challenged this notion. Despite these advance
Externí odkaz:
https://doaj.org/article/01bc46bf52a44bc3a5e6747132c8d723
Autor:
Bobby C Liaw, Che-Kai Tsao, Sonia Seng, Tomi Jun, Yixuan Gong, Matthew D Galsky, William K Oh
Publikováno v:
The oncologist.
Background In the phase III SPARC trial, satraplatin, an oral platinum analogue, demonstrated anticancer activity in men with metastatic castration-resistant prostate cancer (mCRPC). Repeat biopsies are uncommon in mCRPC, limiting the feasibility of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12964e664edc6196ada3d034d47e69a7
https://pubmed.ncbi.nlm.nih.gov/36519763
https://pubmed.ncbi.nlm.nih.gov/36519763
Autor:
Menggang Yu, Sonia Seng, Ziyue Liu, Guru Sonpavde, Sophia Chiu, Che-Kai Tsao, Matthew D. Galsky, Tracy Proverbs-Singh, Noah M. Hahn, Toni K. Choueiri, William Oh
Publikováno v:
Journal of Clinical Oncology. 30:4416-4426
Purpose Several reports suggest that cisplatin is associated with an increased risk of thromboembolism. However, because the excess risk of venous thromboembolic events (VTEs) with cisplatin-based chemotherapy has not been well described, we conducte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16be2047a68740f5f089346eb8b4ddfc
https://doi.org/10.1200/jco.2012.42.4358
https://doi.org/10.1200/jco.2012.42.4358
Autor:
William Oh, Sophia Chiu, Tracy Proverbs-Singh, Sonia Seng, Che-Kai Tsao, Guru Sonpavde, Toni K. Choueiri, Noah M. Hahn, Menggang Yu, Matthew D. Galsky, Ziyue Liu
Publikováno v:
JNCI: Journal of the National Cancer Institute. 104:1837-1840
Cisplatin has been associated with an increased risk of arterial thromboembolic events (ATEs). However, because this association is mostly based on case reports and retrospective studies, we conducted a systemic review and meta-analysis of randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8590161a21d3d0dece3de5056cc283
https://doi.org/10.1093/jnci/djs435
https://doi.org/10.1093/jnci/djs435
Publikováno v:
Clinical Investigation. 1:533-541
Prostate cancer, the most common nonskin cancer in men, is estimated to cause 27,000 deaths annually in the USA. With the advent of prostate-specific antigen screening, most are diagnosed with local disease, but approximately one-third of patients ul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::902bb082a1e0ee174d62035b581a7fef
https://doi.org/10.4155/cli.11.28
https://doi.org/10.4155/cli.11.28
Autor:
Daniel Mulkerin, David S. Hong, Elena G. Chiorean, Sonia Seng, Matthew D. Galsky, William Oh, Luis H. Camacho, Dean F. Bajorin
Publikováno v:
Clinical genitourinary cancer. 9(1)
Satraplatin is a novel platinum agent with favorable clinical attributes including oral bioavailability and lack of significant treatment-associated neuropathy and nephropathy. Furthermore, preclinical studies have shown that satraplatin is active is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56436b810bebad87661df3b87d0b800b
https://pubmed.ncbi.nlm.nih.gov/21700509
https://pubmed.ncbi.nlm.nih.gov/21700509